SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Bin Zhang, Xia Zhang, Tao Zhou, Jiwei Liu, Clinical observation of liver cancer patients treated with axitinib and cabozantinib after failed sorafenib treatment: a case report and literature review, Cancer Biology & Therapy, 2015, 16, 2, 215

    CrossRef

  2. 2
    Antoine Hollebecque, David Malka, Charles Ferté, Michel Ducreux, Valérie Boige, Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons, European Journal of Cancer, 2015, 51, 3, 327

    CrossRef

  3. 3
    Marwan Fakih, A Case of Fibrolamellar Cancer With a Palliative Response and Minor Radiographic Regression With Erlotinib and Bevacizumab Combination Therapy, American Journal of Therapeutics, 2014, 21, 6, e207

    CrossRef

  4. 4
    Marielle Reataza, David K. Imagawa, Advances in managing hepatocellular carcinoma, Frontiers of Medicine, 2014, 8, 2, 175

    CrossRef

  5. 5
    Lorenzo Fornaro, Caterina Vivaldi, Chiara Caparello, Rodolfo Sacco, Virginia Rotella, Gianna Musettini, Sauro Luchi, Edi Editta Baldini, Alfredo Falcone, Gianluca Masi, Dissecting signaling pathways in hepatocellular carcinoma: new perspectives in medical therapy, Future Oncology, 2014, 10, 2, 285

    CrossRef

  6. 6
    Anuj Patel, Weijing Sun, Molecular Targeted Therapy in Hepatocellular Carcinoma: From Biology to Clinical Practice and Future, Current Treatment Options in Oncology, 2014, 15, 3, 380

    CrossRef

  7. 7
    Carmen Berasain, Matías A. Avila, The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis, Journal of Gastroenterology, 2014, 49, 1, 9

    CrossRef

  8. 8
    Jeroen Dekervel, Jos van Pelt, Chris Verslype, Advanced unresectable hepatocellular carcinoma, Current Opinion in Oncology, 2013, 25, 4, 409

    CrossRef

  9. 9
    Jean K. Lee, Ghassan K. Abou-Alfa, An Update on Clinical Trials in the Treatment of Advanced Hepatocellular Carcinoma, Journal of Clinical Gastroenterology, 2013, 47, S16

    CrossRef

  10. 10
    Monica Dandona Desai, Bikramajit Singh Saroya, Albert Craig Lockhart, Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers, Expert Opinion on Investigational Drugs, 2013, 22, 3, 341

    CrossRef

  11. 11
    Kunjali T. Padhya, Jorge A. Marrero, Amit G. Singal, Recent advances in the treatment of hepatocellular carcinoma, Current Opinion in Gastroenterology, 2013, 29, 3, 285

    CrossRef

  12. 12
    Sook Ryun Park, Myrtle Davis, James H. Doroshow, Shivaani Kummar, Safety and feasibility of targeted agent combinations in solid tumours, Nature Reviews Clinical Oncology, 2013, 10, 3, 154

    CrossRef

  13. 13
    Gaetano Bertino, Isidoro Di Carlo, Annalisa Ardiri, Giuseppe Stefano Calvagno, Shirin Demma, Giulia Malaguarnera, Nicoletta Bertino, Mariano Malaguarnera, Adriana Toro, Michele Malaguarnera, Systemic therapies in hepatocellular carcinoma: present and future, Future Oncology, 2013, 9, 10, 1533

    CrossRef

  14. 14
    Stephen L Chan, Tony Mok, Targeted therapy for hepatocellular carcinoma: current status and future direction, Clinical Investigation, 2013, 3, 1, 83

    CrossRef

  15. 15
    Andrew X. Zhu, Molecularly Targeted Therapy for Advanced Hepatocellular Carcinoma in 2012: Current Status and Future Perspectives, Seminars in Oncology, 2012, 39, 4, 493

    CrossRef

  16. 16
    Seung Kew Yoon, Target Therapy for Hepatocellular Carcinoma, Hanyang Medical Reviews, 2012, 32, 2, 118

    CrossRef